Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.

Neurology. 2009 Jul 7;73(1):32-8. doi: 10.1212/WNL.0b013e3181aa29fe. Epub 2009 May 20.

2.

Epstein-Barr virus and disease activity in multiple sclerosis.

Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, van Doorn PA, van der Meché FG, Hintzen RQ.

J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1377-81.

4.

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2005 May 25;293(20):2496-500.

PMID:
15914750
5.

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O.

Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19.

PMID:
24842958
6.

Multiple sclerosis and Epstein-Barr virus.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2003 Mar 26;289(12):1533-6. Retraction in: Ascherio A, Rubertone M, Spiegelman D, Levin L, Munger K, Peck C, Lennette E. JAMA. 2005 May 25;293(20):2466.

PMID:
12672770
7.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Gieß RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

PLoS One. 2017 Apr 7;12(4):e0175279. doi: 10.1371/journal.pone.0175279. eCollection 2017.

8.

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.

JAMA. 2001 Dec 26;286(24):3083-8.

PMID:
11754673
9.

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.

Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L.

Neurology. 2004 Jun 22;62(12):2277-82.

PMID:
15210894
11.

Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.

Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.

J Med Virol. 2003 Aug;70(4):617-23.

PMID:
12794726
12.

Epstein-Barr virus reactivation and multiple sclerosis.

Torkildsen Ø, Nyland H, Myrmel H, Myhr KM.

Eur J Neurol. 2008 Jan;15(1):106-8. Epub 2007 Nov 27.

PMID:
18042233
13.

Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.

Ingram G, Bugert JJ, Loveless S, Robertson NP.

Eur J Neurol. 2010 Nov;17(11):1386-9. doi: 10.1111/j.1468-1331.2010.03083.x.

PMID:
20482607
14.

Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.

Castellazzi M, Delbue S, Elia F, Gastaldi M, Franciotta D, Rizzo R, Bellini T, Bergamaschi R, Granieri E, Fainardi E.

Dis Markers. 2015;2015:901312. doi: 10.1155/2015/901312. Epub 2015 May 26.

15.

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.

Schlemm L, Giess RM, Rasche L, Pfuhl C, Wakonig K, Behrens JR, Scheibenbogen C, Bellmann-Strobl J, Paul F, Reimer U, Ruprecht K.

J Neuroimmunol. 2016 Aug 15;297:56-62. doi: 10.1016/j.jneuroim.2016.05.012. Epub 2016 May 13.

PMID:
27397076
16.

The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.

Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M.

Cell Immunol. 2015 Mar;294(1):9-12. doi: 10.1016/j.cellimm.2015.01.009. Epub 2015 Jan 28.

PMID:
25666504
17.
18.

Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.

Castellazzi M, Tamborino C, Cani A, Negri E, Baldi E, Seraceni S, Tola MR, Granieri E, Contini C, Fainardi E.

Mult Scler. 2010 Jul;16(7):883-7. doi: 10.1177/1352458510368051. Epub 2010 May 18.

PMID:
20483883
19.

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.

Almohmeed YH, Avenell A, Aucott L, Vickers MA.

PLoS One. 2013 Apr 9;8(4):e61110. doi: 10.1371/journal.pone.0061110. Print 2013. Review.

20.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621

Supplemental Content

Support Center